Open AccessChemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
Author(s) -
Laura J. Esserman,
Donald A. Berry,
Maggie C.U. Cheang,
Christina Yau,
Charles M. Perou,
Lisa A. Carey,
Angela De Michele,
Joe W. Gray,
Kathleen ConwayDorsey,
Marc E. Lenburg,
Meredith Buxton,
Sarah Davis,
Laura J. van’t Veer,
Clifford A. Hudis,
Koei Chin,
Denise M. Wolf,
Helen Krontiras,
Leslie D. Montgomery,
Debu Tripathy,
Constance D. Lehman,
Minetta C. Liu,
Olufunmilayo I. Olopade,
Hope S. Rugo,
John T. Carpenter,
Chad Livasy,
Lynn G. Dressler,
David C. Chhieng,
Baljit Singh,
Carolyn Mies,
Joseph T. Rabban,
Yunni Yi Chen,
Dilip D. Giri,
Alfred Au,
Nola M. Hylton
Publication year - 2012
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/cbv3-3753
Subject(s) - oncology , breast cancer , medicine , biomarker , chemotherapy , neoadjuvant therapy , cancer , biology , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom